New procedure aims to stop brain bleeds from coming back
NCT ID NCT06163547
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests a procedure called middle meningeal artery (MMA) embolization for people with chronic subdural hematomas—a buildup of blood on the brain that can cause confusion and weakness. The study will see if blocking the artery that feeds the hematoma can prevent it from returning after surgery or even treat it without surgery. About 180 adults with symptomatic or stubborn hematomas will take part across multiple centers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Middle meningeal artery embolization (a minimally invasive procedure that blocks blood flow to the hematoma)
What this could lead to
If it works, this could offer a less invasive way to treat chronic subdural hematomas and reduce the need for repeat surgeries.
What could go wrong
This is a mid-stage trial with 180 participants, so results are not yet proven. The procedure carries risks like bleeding or allergic reaction to contrast dye, and it may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SUBDURAL HEMATOMAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
EOC
RECRUITINGLugano, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Geneva University Hospitals
RECRUITINGGeneva, Switzerland
Contact